Personalized Therapy for Esophagogastric Cancer Using Thymidylate Synthase Genetic Markers

NCT02296671 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Was unable to accrue any patients

Conditions

Esophagogastric Cancer

Interventions

DRUG: Pemetrexed
DRUG: Oxaliplatin
DRUG: Leucovorin
DRUG: Fluorouracil
GENETIC: Germline genotyping analyses for TSER

Sponsor

Washington University School of Medicine

Collaborators

[object Object]